New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Delta 9 Cannabis Inc.
DN.TO
Shape
US Flag

TSX

Unprofitable

Unprofitable

2M

Drug Manufacturers - Specialty & Generic

Next Earning date - 12 Nov 2024

2M

Drug Manufacturers - Specialty & Generic

Next Earning date - 12 Nov 2024

0.01CAD
Shape-0.01 ( -50.00%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

86%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

93%

Quote Panel

Shape
Updated October 3, 2024
1W % 1M % 3M 0.00 % 1Y -71.43 %

Key Metrics

Shape
  • Market Cap

    1.51M


  • Shares Outstanding

    302.18M


  • Share in Float

    264.85M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    0.005


  • Average Volume

    905459


  • Beta

    1.212


  • Range

    0.005-0.07


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.delta9.ca


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.02x

P/S Ratio

-0.11x

P/B Ratio

-4.6

Debt/Equity

-27.7%

Net Margin

$-0.1

EPS

How DN.TO compares to sector?

P/E Ratio

Relative Strength

Shape

DN.TO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$87M

Shape425%

2025-Revenue

0

$5M

Shape-78%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.21

arrow
arrow

N/A

-0.04
vs -0.04

Q1.22

arrow
arrow

N/A

-0.04
vs -0.04

Q2.22

arrow
arrow

N/A

-0.06
vs -0.01

Q3.22

arrow
arrow

N/A

-0.08
vs -0.01

Q4.22

arrow
arrow

N/A

-0.08
vs -0.04

Q1.23

arrow
arrow

N/A

-0.02
vs -0.04

Q2.23

arrow
arrow

N/A

-0.02
vs -0.06

Q3.23

arrow
arrow

N/A

-0.03
vs -0.08

Q4.23

arrow
arrow

N/A

-0.03
vs -0.08

Q1.24

arrow
arrow

N/A

-0.02
vs -0.02

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.21

arrow
arrow

+21%

17.1M  vs 14.1M

Q1.22

arrow
arrow

-6%

12.5M  vs 13.2M

Q2.22

arrow
arrow

+4%

17.5M  vs 16.8M

Q3.22

arrow
arrow

+3%

15.7M  vs 15.2M

Q4.22

arrow
arrow

+3%

17.6M  vs 17.1M

Q1.23

arrow
arrow

+35%

16.9M  vs 12.5M

Q2.23

arrow
arrow

+4%

18.3M  vs 17.5M

Q3.23

arrow
arrow

+17%

18.4M  vs 15.7M

Q4.23

arrow
arrow

0%

17.5M  vs 17.6M

Q1.24

arrow
arrow

-2%

16.5M  vs 16.9M

Return on EquityShape

status-upQoQ

Q2.22

arrow
arrow

-38%

-0.38
vs -0.18

Q3.22

arrow
arrow

-61%

-0.61
vs -0.38

Q4.22

arrow
arrow

-187%

-1.87
vs -0.61

Q1.23

arrow
arrow

-75%

-0.75
vs -1.87

Q2.23

arrow
arrow

-113%

-1.13
vs -0.75

Q3.23

arrow
arrow

+423%

4.23
vs -1.13

Q4.23

arrow
arrow

+86%

0.86
vs 4.23

Q1.24

arrow
arrow

+50%

0.5
vs 0.86

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News